Urine test to guide early treatment in type 2 diabetes
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 2 diabetes but not severe heart failure (class IV).
- You can understand and sign a consent form.
- You do not have advanced kidney disease (e.g., needing dialysis or having a transplant).
- You are not pregnant or planning to become pregnant, and use effective birth control if needed.
- You have not had a heart attack or stroke in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily medication can slow down kidney damage in people with type 1 diabetes who already have some kidney problems. It may help protect your kidneys from getting worse.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
This study tests if matching treatments to your specific kidney disease markers can better protect your kidneys. It looks at how well Finerenone, Dapagliflozin, and Semaglutide work alone or in a sequence.
This trial tests a combination of treatments to lower the risk of heart disease and kidney problems in people with type 1 diabetes who already have some complications or higher risk. If you qualify, you will receive extra care aimed at preventing heart attacks, strokes, and kidney failure.
This Phase 2 study compares tofogliflozin to metformin to see how well they reduce urine albumin levels (a marker of kidney stress) in people with diabetic kidney disease. You might benefit if your type 2 diabetes is affecting your kidneys despite standard blood-pressure medicines.
This study tests whether adding dulaglutide to your current diabetes and kidney treatment can slow down kidney disease. It's designed for people with type 2 diabetes who have chronic kidney problems and are already on two specific medicines.
Hear when a new Type 2 DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.